7:19 PM · Sep 23, 2021
9/23/2021 Investigating Correlation Between Graphene Oxide, Bioluminesence, Therapudic Gene Inhibiting To Target Illness, Enhanced Productivity Observance, Drug Delivery And Relation To Ties With New Experimental Covid Vaccine
Abstract
Since on or before 2013 scientists (especially in the east) have been researching uses of graphene oxide, and bioluminesence to "target cancer cells" in the human body. The use of these (graphene oxide and bioluminesence) is to target specific cancer or "illness" cells and monitor how it works while delivering the different drugs used in each study. This report is to illustrate the true directive of the research results stemmed from these studies done on different combinations of substances to enhance drug delivery and eliminate specific genes using therapudic techniques.
Hypothesis
In my recent research I have found that there are ingredients in the covid vaccines, un-reported by manufacturers, which having been tested are the same ingredients used in conducted studies on cancer treatment using graphene oxide and magnetic materials in combination with bioluminesence resulting in the distribution of what I now know to be the mark of the beast. (Luciferase: "Luciferase is a generic term for the class of oxidative enzymes that produce bioluminescence, and is usually distinguished from a photoprotein." (Ref. Wikipedia https://en.wikipedia.org/wiki/Luciferase))
Luciferase:
Luciferase is a light-producing enzyme naturally found in insect fireflies and in luminous marine and terrestrial microorganisms.
(Ref. https://www.sciencedirect.com/topics/neuroscience/luciferase)
The name Lucifer is well known to be an alias of satan himself. (Name of the beast aka dragon)
Luciferase is bioluminescent material, which glows under a black light. (Mark of the beast)
(↓Number of the beast is 666 (060606))
Patent # WO2020060606 - CRYPTOCURRENCY SYSTEM USING BODY ACTIVITY DATA
(Ref. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020060606)
(Patent Abstract:
Human body activity associated with a task provided to a user may be used in a mining process of a cryptocurrency system. A server may provide a task to a device of a user which is communicatively coupled to the server. A sensor communicatively coupled to or comprised in the device of the user may sense body activity of the user. Body activity data may be generated based on the sensed body activity of the user. The cryptocurrency system communicatively coupled to the device of the user may verify if the body activity data satisfies one or more conditions set by the cryptocurrency system, and award cryptocurrency to the user whose body activity data is verified.)
(Ref. https://patentscope.wipo.int/search/en/detail.jsf?docId=US291464337&_fid=WO2020060606)
Investigating correlation between graphene oxide, bioluminesence & therapudic gene inhibiting to target illness and enhance productivity observance
Analysis:
Scientists have been doing experiments and reports on the use of graphene oxide in medical treatments for many years.
USING CANCER PATIENTS AS SUBJECTS
NOT CALLED "VACCINE" IN STUDIES BUT RATHER TO DELIVER OTHER PARTICALS & OBSERVE REACTIONS AND ABILITY
FINDINGS BASED ON RESEARCH OF DISSECTING THE
INGREDIENTS OF THE EXPERIMENTAL COVID "VACCINES" WHICH ARE NOT BASED ON THE SAME PROPERTIES AS THE ORIGINAL DEFINITION OF VACCINE BUT RATHER THE EDITED DEFINITION WHICH INCLUDES THERAPUDIC GENE MODIFICATION. THIS WAS, NOW APPARANTLY, NECESSARRY TO PROVE THAT THE INGREDIENTS LISTED BY THE MANUFACTURER ARE NOT THE COMPLETE LIST OF WHAT THE SUBSTANCE CONTAINS. THESE EXPERIMENTAL "VACCINES" ARE INTERNAL NANO GENE EDITING MATERIAL.
ON 4/13/2005 BILL GATES DID A DEMONSTRATION ABOUT A VACCINE THAT COULD EDIT YOUR GENES TO NOT BELIEVE IN GOD!
(SEE VIDEO HERE: Gates Kills "God Gene" With √ĀƔ https://rumble.com/vm314v-gates-kills-god-gene.html)
YOU MAY HAVE SEEN THE VIDEOS CIRCULATING OF PEOPLE WHO HAVE BEEN VACCINATED LITERALLY STICKING METAL TO THEMSELVES LIKE A MAGNET.
Gadolinium is magnetic:
Gadolinium:
(Used in MRI) is a chemical element with the symbol Gd and atomic number 64. Gadolinium is a silvery-white metal when oxidation is removed. It is only slightly malleable and is a ductile rare-earth element. Gadolinium reacts with atmospheric oxygen or moisture slowly to form a black coating.
(Ref Wikipedia https://en.wikipedia.org/wiki/Gadolinium#:~:text=Gadolinium%20is%20a%20chemical%20element,to%20form%20a%20black%20coating.)
Does gadolinium have metal in it?
Gadolinium is a soft, shiny, ductile, silvery metal belonging to the lanthanide group of the periodic chart. The metal does not tarnish in dry air but an oxide film forms in moist air.
(Ref. Chemical Properties of gadolinium - Health effects of gadolinium - Environmental effects of gadolinium https://www.lenntech.com/periodic/elements/gd.htm)
Is Gadolinium magnetic?
Gadolinium is paramagnetic at room temperature, with a ferromagnetic Curie point of 20 °C (68 °F). Paramagnetic ions, such as gadolinium, enhance nuclear relaxation rates, making gadolinium useful for magnetic resonance imaging (MRI).
(Ref. Wikipedia https://en.wikipedia.org/wiki/Gadolinium#:~:text=Gadolinium%20is%20paramagnetic%20at%20room,magnetic%20resonance%20imaging%20(MRI).)
Why is gadolinium used in MRI?
Gadolinium contrast medium is used in about 1 in 3 of MRI scans to improve the clarity of the images or pictures of your body's internal structures. This improves the diagnostic accuracy of the MRI scan. For example, it improves the visibility of inflammation, tumours, blood vessels and, for some organs, blood supply.
(Ref. Gadolinium Contrast Medium (MRI Contrast agents) https://www.insideradiology.com.au/gadolinium-contrast-medium/)
What are the possible side effects of gadolinium?
The most common side effects include injection site pain, nausea, itching, rash, headaches and dizziness. Serious but rare side effects such as gadolinium toxicity and nephrogenic systemic fibrosis, or NSF, are most often seen in patients with severe kidney problems.
(Ref. Gadolinium Side Effects https://www.drugwatch.com/gadolinium/side-effects/)
Graphene oxide in medical research since discovery in 2004:
(Ref. Discovery of graphene https://www.graphene.manchester.ac.uk/learn/discovery-of-graphene/)
Quantum dots as a promising agent to combat COVID‐19 (documents)
On March 27 2013 NCBI reported:
A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells
"Gene silencing was evaluated by reverse transcription polymerase chain reaction and PAMAM-PEG-cRGD-siRNA complex downregulated the expression of hERG to 26.3% of the control value. Furthermore, gene knockdown of hERG elicited growth suppression as well as activated apoptosis by means of abolishing vascular endothelial growth factor secretion and triggering caspase-3 cascade in anaplastic thyroid carcinoma cells. Our study demonstrates that this novel triblock polymer, PAMAM-PEG-cRGD, exhibits negligible cytotoxicity, effective transfection, "smart" cancer targeting, and therefore is a promising siRNA nanocarrier."
(Ref. Quantum dots as a promising agent to combat COVID‐19 (documents)
https://pubmed.ncbi.nlm.nih.gov/23569377/)
On November 24th 2013 Nature.com reported:
Photocurrent generation in semiconducting and metallic carbon nanotubes
Abstract:
"The fundamental mechanism underlying photocurrent generation in carbon nanotubes1,2,3 has long been an open question. In photocurrent generation, the temperature of the photoexcited charge carriers determines the transport regime by which the electrons and holes are conducted through the nanotube. Here, we identify two different photocurrent mechanisms for metallic and semiconducting carbon nanotube devices with induced p–n junctions4,5,6,7."
(Ref. Photocurrent generation in semiconducting and metallic carbon nanotubes
https://www.nature.com/articles/nphoton.2013.311?page=2)
On May 6 2014 NCBI reported:
Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging
"Here we present nanoparticles of poly(amidoamine) dendrimer-grafted gadolinium-functionalized nanographene oxide (Gd-NGO) as effective carriers to deliver both chemotherapeutic drugs and highly specific gene-targeting agents such as microRNAs (miRNAs) to cancer cells. The positively charged surface of Gd-NGO was capable of simultaneous adsorption of the anti-cancer drug epirubicin (EPI) and interaction with negatively charged Let-7g miRNA. Using human glioblastoma (U87) cells as a model, we found that this conjugate of Let-7g and EPI (Gd-NGO/Let-7g/EPI) not only exhibited considerably higher transfection efficiency, but also induced better inhibition of cancer cell growth than Gd-NGO/Let-7g or Gd-NGO/EPI. The concentration of Gd-NGO/Let-7g/EPI required for 50% inhibition of cellular growth (IC50) was significantly reduced (to the equivalent of 1.3 μg/mL EPI) compared to Gd-NGO/EPI (3.4 μg/mL EPI). In addition, Gd-NGO/Let-7g/EPI could be used as a contrast agent for magnetic resonance imaging to identify the location and extent of blood-brain barrier opening and quantitate drug delivery to tumor tissues. These results suggest that Gd-NGO/Let-7g/EPI may be a promising non-viral vector for chemogene therapy and molecular imaging diagnosis in future clinical applications."
(Ref. Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging https://pubmed.ncbi.nlm.nih.gov/24811259/)
On March 16th 2016 NCBI reported:
Graphene Oxide and Gadolinium-Chelate Functionalized Poly(lactic acid) Nanocapsules Encapsulating Perfluorooctylbromide for Ultrasound/Magnetic Resonance Bimodal Imaging Guided Photothermal Ablation of Cancer
"This paper successfully fabricated a novel multifunctional theranostic agent (PFOB@PLA/GO/Gd-DTPA NCs) by loading perfluorooctylbromide (PFOB) into poly(lactic acid) (PLA) nanocapsules (NCs) followed by surface functionalization with graphene oxide (GO) and gadolinium-chelate (Gd-DTPA). It was found that the resulting nanoagent could serve as a contrast agent simultaneously to enhance ultrasound (US) and magnetic resonance imaging (MRI). Benefiting from the strong absorption in the near infrared (NIR) region, the nanocapsules could efficiently kill cancer cells under NIR laser irradiation. Thus, such a single theranostic agent with the combination of realtime US imaging and high-resolution MR imaging could achieve great therapeutic effectiveness without systemic damage to the body. In addition, the cytotoxicity assay on HUVEC cells revealed a good biocompatibility of PFOB@PLA/GO/Gd-DTPA NCs, showing that the versatile nanocapsule system may hold great potential as an effective nanoplatform for contrast enhanced imaging guided photothermal therapy."
(Ref. Graphene Oxide and Gadolinium-Chelate Functionalized Poly(lactic acid) Nanocapsules Encapsulating Perfluorooctylbromide for Ultrasound/Magnetic Resonance Bimodal Imaging Guided Photothermal Ablation of Cancer https://pubmed.ncbi.nlm.nih.gov/27455619/)
ON APRIL 13 2016 NCBI reported:
Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter"
this is used to deliver "antisense oligonucleotides
"To monitor the delivery of anti-miR-21 into cells and tumors, we also constructed an activatable luciferase reporter (Fluc-3xPS) containing three perfectly complementary sequences against miR-21 in the 3' untranslated region (UTR) of the reporter. Compared with bare dendrimer and Lipofectamine 2000 (Lipo2000), NGO-PEG-dendrimer showed considerably lower cytotoxicity and higher transfection efficiency. As demonstrated by in vitro bioluminescence imaging and Western blotting assays, NGO-PEG-dendrimer effectively delivered anti-miR-21 into the cytoplasm and resulted in the upregulation of luciferase intensity and PTEN target protein expression in a dose-dependent manner. Moreover, transfection with anti-miR-21 by NGO-PEG-dendrimer led to stronger inhibition of cell migration and invasion than did bare dendrimer or Lipo2000 transfection. The intravenous delivery of anti-miR-21 via NGO-PEG-dendrimer induced a significant increase in the bioluminescence signal within the Fluc-3xPS reporter-transplanted tumor areas. These results suggest that NGO-PEG-dendrimer could be an efficient and a potential nanocarrier for delivering RNA oligonucleotides. In addition, the strategy of combining NGO-PEG-dendrimer with an activatable luciferase reporter allows the image-guided monitoring of the delivery process, which can provide insights into the RNA-based cancer treatments."
(Ref. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter" https://pubmed.ncbi.nlm.nih.gov/27010367/)
On may 20th 2017 NCBI reported:
Gadolinium-based layered double hydroxide and graphene oxide nano-carriers for magnetic resonance imaging and drug delivery
"Gadolinium (Gd)-based contrasts remain one of the most accepted contrast agents for magnetic resonance imaging, which is among the world most recognized noninvasive techniques employed in clinical diagnosis of patients. At ionic state, Gd is considered toxic but less toxic in chelate form. A variety of nano-carriers, including gadolinium oxide (Gd2O3) nanoparticles have been used by researchers to improve the T1 and T2 contrasts of MR images. Even more recently, a few researchers have tried to incorporate contrast agents simultaneously with therapeutic agents using single nano-carrier for theranostic applications. The benefit of this concept is to deliver the drugs, such as anticancer drugs and at the same time to observe what happens to the cancerous cells. The delivery of both agents occurs concurrently. In addition, the toxicity of the anticancer drugs as well as the contrast agents will be significantly reduced due to the presence of the nano-carriers. The use of graphene oxide (GO) and layered double hydroxides (LDH) as candidates for this purpose is the subject of current research, due to their low toxicity and biocompatibility, which have the capacity to be used in theranostic researches. We review here, some of the key features of LDH and GO for simultaneous drugs and diagnostic agents delivery systems for use in theranostics applications."
Keywords: Drug delivery; Gadolinium contrast; Graphene oxide; Layered double hydroxides; Magnetic resonance imaging (MRI).
(Ref. Gadolinium-based layered double hydroxide and graphene oxide nano-carriers for magnetic resonance imaging and drug delivery https://pubmed.ncbi.nlm.nih.gov/29086824/)
On august 19th 2019 NCBI reported:
Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide
"Results: XRD, TGA and FTIR studies confirmed the formation of Fe3O4 phase and the presence of iron oxide nanoparticles, polyethylene glycol, LDH and the drug for all the synthesized samples. The size of the nanoparticles co-coated with Mg/Al-LDH is about 27 nm compared to 40 nm when they were co-coated with Zn/Al-LDH, with both showings near uniform spherical shape. The iron oxide nanoparticles retain their superparamagnetic property when they were coated with polyethylene glycol, polyethylene glycol co-coated with Mg/Al-LDH and polyethylene glycol co-coated with Zn/Al-LDH with magnetic saturation value of 56, 40 and 27 emu/g, respectively. The cytotoxicity study reveals that the anticancer nanodelivery system has better anticancer activity than the free drug, 5-FU against liver cancer HepG2 cells and at the same time, it was found to be less toxic to the normal fibroblast 3T3 cells."
"Conclusion: These are unique core-shell nanoparticles synthesized with the presence of multiple functionalities are hoped can be used as a multifunctional nanocarrier with the capability of targeted delivery using an external magnetic field and can also be exploited as hypothermia for cancer cells in addition to the chemotherapy property."
(Ref. Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide https://pubmed.ncbi.nlm.nih.gov/31695362/)
On December 9th 2020 NCBI reported:
Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications
"Abstract
The use of nanocarriers composed of polyethylene glycol- and polyvinyl alcohol-coated vesicles encapsulating active molecules in place of conventional chemotherapy drugs can reduce many of the chemotherapy-associated challenges because of the increased drug concentration at the diseased area in the body. The present study investigated the structure and magnetic properties of iron oxide nanoparticles in the presence of polyvinyl alcohol and polyethylene glycol as the basic surface coating agents. We used superparamagnetic iron oxide nanoparticles (FNPs) as the core and studied their effectiveness when two polymers, namely polyvinyl alcohol (PVA) and polyethylene glycol (PEG), were used as the coating agents together with magnesium-aluminum-layered double hydroxide (MLDH) as the nanocarrier"
(Ref. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications https://pubmed.ncbi.nlm.nih.gov/33298980/)
Conclusion:
Graphene oxide has been in medical use for many years. The fact that it was found in the covid vaccines when tested but un-reported by the manufaturers makes it highly suspicious of malicious activity. Proof that they were using it in studies to "combat covid" along with their claim that graphene oxide is not used in the vaccines as per calims made by all so called "fact checking" sites, marks what seems to be indication that they are using graphene oxide but lying. Which should for any person with common sense be a huge red flag. Even borderline acceptable use as evidence of offence in accusation for legal repercussion.
The combination of all evidence I have presented should make it easier to understand that this "vaccine" is in fact, the mark of the beast.